Grants for Public and State controlled institutions of higher education - Health

The BlueAngel Community Health Grant program at Blue Cross & Blue Shield of Rhode Island aims to fund organizations and programs that will result in more Rhode Islanders being able to afford safe, healthy, and stable housing. The program seeks to increase awareness about safe, affordable housing as a shared public concern and highlight solutions to support access to safe and affordable housing. The grant is open to Rhode Island nonprofit agencies that have qualified for exemption under Section 501(c)(3) of the IRS Code or are public instrumentalities. Funding amounts historically range from $25,000 per year to $75,000 per year. Applicants are invited to submit a Letter of Intent (LOI), which will be reviewed by a BCBSRI LOI Review Subcommittee. Selected agencies will then be invited to submit full proposals for funding. Site visits will be conducted by Community Relations staff with each of the finalist organizations. The 2024 grant application cycle is closed, and funding awards begin in January 2024. For more information or questions, potential applicants can email [email protected].

The United States Agency for International Development in Southern Africa (USAID/SouthernAfrica) is seeking Concept Papers from qualified entities to implement an activity entitledHealth Financing and Public Financial Management Systems Strengthening Activity in SouthAfrica. Eligibility for this award is not restricted. The authority for the Notice of FundingOpportunity (NOFO) is found in the Foreign Assistance Act of 1961, as amended.Subject to funding availability and at the discretion of the Agency, USAID intends to provide upto $30 million in total USAID funding over a five (5) year period through a CooperativeAgreement with the selected applicant. Eligible organizations interested in submitting a ConceptPaper are encouraged to read this NOFO thoroughly to understand the type of project sought(Section A), the application submission requirements (Sections C and D), and the evaluationprocess and merit review criteria (Section E). To be eligible for award, the applicant mustprovide all information required in this NOFO and meet eligibility standards in Section C.Concepts must be received by the date and time indicated at the top of this cover letter. Notethat USAID is not accepting full applications at this time - only Concept Papers.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

This funding opportunity supports healthcare organizations in developing innovative quality improvement projects to enhance migraine management and patient care in emergency departments across the United States.

This funding opportunity supports Kuwait-based non-profits, educational institutions, and individuals in creating cultural and educational programs that strengthen ties between the U.S. and Kuwait, with a focus on diversity, inclusion, and shared challenges.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (see RFA-HL-22-010).

This funding opportunity supports research projects that develop and implement community-focused interventions to improve vision health outcomes and address disparities among underserved populations.

The Artistic Legacy Grant (ALG), funded by the San Francisco Arts Commission, offers $10,000 to $100,000 for a 3-year period to support and celebrate an artist who has significantly contributed to San Francisco's arts and culture for at least 25 years, with funds to be used for professional development, artistic planning, sabbaticals, and other related costs.

The grant titled "Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings" aims to use recent advancements in structural biology to study protein assemblies related to Alzheimer's disease and related dementias (AD/ADRD) in their natural environments within cells and tissues, with the goal of developing ligands that can identify and monitor these proteins in patients.

This funding opportunity supports the development of innovative computational tools to enhance the use of the human pangenome in genomic research, particularly for applications in cancer, aging, and diverse populations.

The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This initiative will emphasize the development of skills in data science and drug discovery, and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). This initiative will support early career, independent investigators from diverse backgrounds to gain critical translational skills in data science and drug discovery. The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, precision medicine approach to AD/ADRD treatment, prevention, early detection, and disease management and care.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

This grant provides funding for research projects that implement screening and intervention strategies for alcohol, tobacco, and drug use among adult populations facing health disparities, such as racial minorities and low-income communities.

This funding opportunity supports researchers developing innovative technologies to enhance the delivery of treatments for HIV and substance use disorders, focusing on improving patient outcomes and understanding the effects of addictive substances.

This funding opportunity provides small grants to early-career researchers who have received specific NHLBI K awards, allowing them to expand their research projects or explore new studies that build on their previous work.

The "Early-Stage Dissemination and Implementation Research in Communication Disorders" grant aims to fund preliminary research projects that focus on improving the dissemination and implementation of treatments for hearing, balance, taste, smell, voice, speech, and language disorders, with a requirement to incorporate a Dissemination and Implementation (D&I) process model and other core D&I research elements.

This funding opportunity supports research institutions and organizations in studying biological markers of cognitive decline and dementia in aging individuals with Autism Spectrum Disorders, aiming to improve understanding and assessment of these conditions.

The purpose of this NOFO is to seek applications for a Coordinating Center (CC) for the Multi-Sectoral Preventive Interventions (MSPI) Research Network. Members of the Multi-Sectoral Preventive Interventions (MSPI) Research Network, including the CC and separately funded research projects, will work collaboratively with the NIH to test prospective multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities. The MSPI Research Network will include the CC funded under this Cooperative Agreement and up to 10 Research Projects funded under the companion UG3/UH3 Phased Cooperative Agreement NOFO, Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities. The CC will provide overarching support and guidance to the network in three domains: (1) administration, coordination, and communication; (2) methodology, data, and analytic support and consultation; and (3) community and other collaborator engagement and dissemination support. It is important that applicants for the CC also read the companion NOFO to understand the full mission and structure of the research network.

This grant provides financial support to individuals and organizations working on innovative projects that promote architecture and engage diverse audiences in meaningful discussions about the designed environment.